Helix BioMedix (HXBM) Stock Price, News & Analysis

Company Overview

Helix BioMedix, Inc. is a biotechnology company focused on the discovery, development and commercialization of bioactive peptides. Its peptide technologies are designed for applications in personal care, skin care, wound care and other health-related markets.

The company has developed peptide-based ingredients intended to support products addressing concerns such as skin aging, acne, moisturization and antimicrobial protection. Helix BioMedix has also pursued partnerships and licensing arrangements to incorporate its proprietary peptide compounds into consumer and healthcare products.

Founded in the late 1990s, Helix BioMedix has historically served customers in the cosmetics, personal-care and biotechnology industries, with its technologies positioned for use in international markets. Publicly available information about its current operations and leadership is limited.

Key Stats

• Today's Range: $3.29 to $3.29
• 50-Day Range: $1.02 to $6.50
• 52-Week Range: $1.00 to $6.50
• Volume: N/A
• Average Volume: 30 shs
• Market Capitalization: $723.80 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 10/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:HXBM
• CIK: N/A
• Web: www.helixbiomedix.com
• Phone: (425) 402-8400
• Fax: 425-806-2999
• Employees: 8
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 220,000
• Free Float: 204,000
• Market Cap: $723.80 thousand
• Optionable: Not Optionable
• Beta: 1.80